http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2200006-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88b6445cd1d147b5a0c19551478764b2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13cb1e5f8e567072cd85d6e3765fd853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_058ede2799545b27bb661c87339d1a7f |
| publicationDate | 2003-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2200006-C2 |
| titleOfInvention | Method for prophylaxis of perinatal pathology after arvi-state in women during pregnancy |
| abstract | FIELD: medicine, obstetrics, perinatology. SUBSTANCE: after acute respiratory viral infection (ARVI) pregnant woman should be intramuscularly injected with neovir per 250 mg 7 times every other day along with triovit-therapy, simultaneously. After 3-5 injections of neovir one should carry out a threefold intravenous injection of "Human normal immunoglobulin" preparation per 25 mg every other day. The method provides prevention of severe gestoses, decrease of neonatal hypoxia and edematous-hemorrhagic syndrome. EFFECT: higher efficiency of prophylaxis. 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2489160-C1 |
| priorityDate | 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.